Mealey's (November 20, 2020, 1:32 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Nov. 19 upheld a Delaware federal judge’s denial of a motion for judgment as a matter of law (JMOL) by GlaxoSmithKline LLC (GSK) following a jury trial that led to an award of $89.7 million in patent infringement damages (Vectura Limited v. GlaxoSmithKline LLC, No. 20-1054, Fed. Cir., 2020 U.S. App. LEXIS 36393)....